1 publication

• Published Subscription 17 May 2019

  In Silico Designing of Triazolothiadiazine as Anticancer Agents

  By Monika Kakadiya, Nidhi Joshi, Malleshappa Noolvi, Uttam A. More

  Abstract: Cancer is irregular growth of cells and formation of tumor. There are approximately 9.6 million death reported globally. It is caused by physical or genetic factor. There are various targets for the inhibition of growth of cancerous cells. Inhibition of colchicines binding site of tubulin is promising target in field of cancer management. In this study, we designed 25 novel thiazole and triazolothiadiazine derivatives as colchicine binding site inhibitors and …

  Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 6, Issue 1, 2019 · pp. 10–20 Read article →